Chemical biology consortia operate by leveraging the expertise and resources of multiple stakeholders. They often consist of academic institutions, government agencies, and private sector partners. Collaborative projects within the consortium focus on shared objectives such as drug discovery, biomarker development, and toxicity assessment. These consortia provide a platform for sharing knowledge, technologies, and methodologies, which accelerates the research and development process.
